Skip to main content
Equibles
CLPT logo

CLPT · ClearPoint Neuro, Inc. · Earnings Call Transcripts & Audio

Track CLPT — free

Use CLPT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLPT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.21 +0.44 (+3.74%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$362.24M
Shares
30.50M
Volume · Sep 30 1.25M Avg daily vol (3M) 618.1K

ClearPoint Neuro, Inc. Earnings Call Transcripts

Quarterly earnings calls for ClearPoint Neuro, Inc. (CLPT), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲52.4% $5.20M −$4.30M '22 Q2 22-08-09 ▲12.5% $5.15M −$3.79M '22 Q3 22-11-08 ▲8% $5.43M −$5.61M '23 Q1 23-05-11 ▲14.4% $5.95M −$7.05M '23 Q2 23-08-08 ▲12% $5.76M −$4.81M '23 Q3 23-11-09 ▲31.6% $6.81M −$4.62M '23 Q4 24-01-08 ▲40.6% $7.64M −$4.15M '24 Q1 24-05-07 ▲32.1% $7.86M −$4.41M '24 Q2 24-08-07 ▲41% $8.12M −$4.97M '24 Q3 24-11-07 ▲14.1% $7.77M −$5.39M '24 Q4 25-02-26 ▲11.1% $8.48M −$6.03M '25 Q1 25-05-13 ▲17.3% $9.21M −$5.84M '25 Q2 25-08-12 ▲9.1% $8.86M −$5.89M '25 Q3 25-11-06 ▲34% $10.41M −$7.79M '25 Q4 26-03-17 ▲42.9% $12.13M −$9.55M '26 Q1 26-05-13 LATEST ▲18.1% $10.88M −$11.34M '26 Q2 26-08-03
Earnings call
FY26 · Q2
2026-08-03
ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings Call Transcript
Confident tone FDA regulatory pathway acceleration Focused ultrasound partnership Commercial readiness for partner drug launches
Revenue
$10.88M
▲ 18.1% YoY
Diluted EPS
$-0.38
Gross margin
61.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript
Confident tone Biopharma partner ecosystem and cell/gene therapy pipeline Eeroflow acquisition integration Expense growth and cash burn
Revenue
$12.13M
▲ 42.9% YoY
Diluted EPS
$-0.32
Gross margin
64.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript
Confident tone Four product categories / Fast Forward phase Eris Holdings acquisition integration Cell and gene therapy / Essential Everywhere strategy
Revenue
$10.41M*
▲ 34% YoY
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript
Confident tone IRRAS Merger Biologics and Drug Delivery CRO Facility / Preclinical Services
Revenue
$8.86M
▲ 9.1% YoY
Diluted EPS
$-0.21
Gross margin
63.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript
Confident tone Product introductions (ICT 3.0, PRISM Laser, OR expansion) Cell and gene therapy ecosystem Global installed base and regulatory clearances
Revenue
$9.21M
▲ 17.3% YoY
Diluted EPS
$-0.21
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript
Confident tone Capital equipment and site placements Cell and gene therapy / biologics and drug delivery Software and new product launches (3.0, PRISM)
Revenue
$8.48M
▲ 11.1% YoY
Diluted EPS
$-0.22
Gross margin
60.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript
Confident tone Cell and gene therapy delivery ecosystem Fast. Forward strategic phase New product launches and innovation
Revenue
$7.77M*
▲ 14.1% YoY
Gross margin
61.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript
Confident tone Biologics and Drug Delivery Growth SmartFrame OR Expansion Gross Margin Outlook
Revenue
$8.12M
▲ 41% YoY
Diluted EPS
$-0.18
Gross margin
59.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript
Confident tone Four-Pillar Growth Strategy Capital Equipment and Software Expansion New Product Launches and Innovation
Revenue
$7.86M
▲ 32.1% YoY
Diluted EPS
$-0.16
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript
Confident tone Capital placements (SmartFrame OR and PRISM Laser) Four-pillar growth strategy Biologics and drug delivery partners
Revenue
$7.64M
▲ 40.6% YoY
Diluted EPS
$-0.16
Gross margin
59.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
ClearPoint Neuro, Inc. (CLPT) Q4 2023 Earnings Call Transcript
Confident tone Biologics and Drug Delivery Growth International Expansion and EU MDR Certification Four-Pillar Growth Strategy
Revenue
$6.81M*
▲ 31.6% YoY
Gross margin
58.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
ClearPoint Neuro, Inc. (CLPT) Q3 2023 Earnings Call Transcript
Revenue
$5.76M
▲ 12% YoY
Diluted EPS
$-0.20
Gross margin
56.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
ClearPoint Neuro, Inc. (CLPT) Q2 2023 Earnings Call Transcript
Revenue
$5.95M
▲ 14.4% YoY
Diluted EPS
$-0.29
Gross margin
52.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
ClearPoint Neuro, Inc. (CLPT) Q1 2023 Earnings Call Transcript
Revenue
$5.43M
▲ 8% YoY
Diluted EPS
$-0.23
Gross margin
58.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-11-08
ClearPoint Neuro, Inc. (CLPT) Q3 2022 Earnings Call Transcript
Revenue
$5.15M
▲ 12.5% YoY
Diluted EPS
$-0.15
Gross margin
71.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript
Revenue
$5.20M
▲ 52.4% YoY
Diluted EPS
$-0.18
Gross margin
62.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Call Transcript
Revenue
$5.03M
▲ 24.8% YoY
Diluted EPS
$-0.17
Gross margin
64.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-14
ClearPoint Neuro, Inc. (CLPT) Q4 2021 Earnings Call Transcript
Revenue
$4.28M*
▲ 15.2% YoY
Gross margin
74.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
ClearPoint Neuro, Inc. (CLPT) Q3 2021 Earnings Call Transcript
Revenue
$4.57M
▲ 30% YoY
Diluted EPS
$-0.18
Gross margin
66.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
ClearPoint Neuro, Inc. (CLPT) Q2 2021 Earnings Call Transcript
Revenue
$3.41M
▲ 37.7% YoY
Diluted EPS
$-0.17
Gross margin
66.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Call Transcript
Revenue
$4.03M
▲ 29.3% YoY
Diluted EPS
$-0.13
Gross margin
64.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
ClearPoint Neuro, Inc. (CLPT) Q4 2020 Earnings Call Transcript
Revenue
$3.72M*
▲ 15.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
ClearPoint Neuro, Inc. (CLPT) Q3 2020 Earnings Call Transcript
Revenue
$3.52M
▲ 20.2% YoY
Gross margin
74.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-12
ClearPoint Neuro, Inc. (CLPT) Q2 2020 Earnings Call Transcript
Revenue
$2.48M
▼ 4.9% YoY
Gross margin
67.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-16
ClearPoint Neuro, Inc. (CLPT) Q1 2020 Earnings Call Transcript
Revenue
$3.12M
▲ 26% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1285550 CUSIP 18507C103 13F (30d) 2 filings 2 filers Visit website Investor relations